1. Home
  2. ENOV vs FORM Comparison

ENOV vs FORM Comparison

Compare ENOV & FORM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • FORM
  • Stock Information
  • Founded
  • ENOV 1995
  • FORM 1993
  • Country
  • ENOV United States
  • FORM United States
  • Employees
  • ENOV N/A
  • FORM N/A
  • Industry
  • ENOV Fluid Controls
  • FORM Semiconductors
  • Sector
  • ENOV Industrials
  • FORM Technology
  • Exchange
  • ENOV Nasdaq
  • FORM Nasdaq
  • Market Cap
  • ENOV 2.1B
  • FORM 2.2B
  • IPO Year
  • ENOV 2008
  • FORM N/A
  • Fundamental
  • Price
  • ENOV $30.11
  • FORM $32.55
  • Analyst Decision
  • ENOV Strong Buy
  • FORM Buy
  • Analyst Count
  • ENOV 5
  • FORM 7
  • Target Price
  • ENOV $58.00
  • FORM $41.17
  • AVG Volume (30 Days)
  • ENOV 1.3M
  • FORM 648.2K
  • Earning Date
  • ENOV 08-06-2025
  • FORM 07-30-2025
  • Dividend Yield
  • ENOV N/A
  • FORM N/A
  • EPS Growth
  • ENOV N/A
  • FORM N/A
  • EPS
  • ENOV N/A
  • FORM 0.69
  • Revenue
  • ENOV $2,150,191,000.00
  • FORM $766,230,000.00
  • Revenue This Year
  • ENOV $8.23
  • FORM $2.18
  • Revenue Next Year
  • ENOV $6.18
  • FORM $7.14
  • P/E Ratio
  • ENOV N/A
  • FORM $47.06
  • Revenue Growth
  • ENOV 18.32
  • FORM 15.33
  • 52 Week Low
  • ENOV $29.13
  • FORM $22.58
  • 52 Week High
  • ENOV $49.83
  • FORM $63.63
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 38.02
  • FORM 50.93
  • Support Level
  • ENOV $31.48
  • FORM $33.35
  • Resistance Level
  • ENOV $32.61
  • FORM $35.02
  • Average True Range (ATR)
  • ENOV 1.11
  • FORM 1.22
  • MACD
  • ENOV -0.11
  • FORM -0.09
  • Stochastic Oscillator
  • ENOV 20.12
  • FORM 48.05

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About FORM FormFactor Inc. FormFactor Inc.

FormFactor Inc is a provider of electrical and optical test and measurement technologies along the full semiconductor product lifecycle - from characterization, modeling, reliability, and design de-bug, to qualification and production test.. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.

Share on Social Networks: